Effects of hydro-ethanolic extract of berberis vulgaris fruit on rabbit isolated heart

Daru

Volumn 14, Issue 4, 2006, Pages 208-213

  Parsaee, H ^a   Shafei, M N ^a   Boskabady, M H ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Berberis vulgaris; Calcium channel blocker; Isolated heart; Rabbit

Indexed keywords

ALKALOID; CALCIUM; CALCIUM CHANNEL; DILTIAZEM; ETHANOLIC EXTRACT OF BERBERIS VULGARIS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AORTA; ARTICLE; BERBERIS; CHEMICAL ANALYSIS; CIRCULATION; CITRIC ACID CYCLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART MUSCLE CONTRACTILITY; HEART PERFUSION; HEART RATE; ISOLATED HEART; MALE; NONHUMAN; RABBIT;

EID: 33846866777     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. th ed. Vol.1, 2001. P. 1.
2. Gilani AH, Janbaz KH, Aziz N, Herzig JU, Kazemi M, Choudhary MI, Herzig JW. Possible mechanism of selective inotropic activity of the n-butanolic fraction from berberis aristata fruit. Gen Pharmacol 1999, 33 (5): 407-444.
3. Zargari A. Medicinal plants. Vol.2. Tehran university publications, Tehran, Iran, 1992, P 281-284.
4. Gilani AH, Janbaz KH. Preventive and curative effects of Berberis aristata fruit extract on paracetamol and CCl4-induced hepatotoxicity. Phytother Res 1995, 9: 489-494.
5. Hwang JM, Wang CJ, Chou FP, Tseng TH, Hsieh YS, Lin WL, Chu CY. Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver. Arch Toxicol 2002; 76: 664-670
6. Lau CW, Yao XQ. Cardiovascular actions of berberine. Cardiovascular Drug Rev 2001, 19 (3): 234- 44.
7. Bhandari D.K, Nath G, Ray A.B, Tewari P.V. Antimicrobial activity of crude extract from Berberis Asiatica stem bark. Pharmaceutical Biol 2000, 38 (4): 254-7.
8. Yu HH, Kim KJ, Cha JD, Kim HK, Lee YE, Choi NY, You YO. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. J Med Food 2005, 8(4):454-61.
9. Shaffer JE. Inotropic and chronotropic activity of berberine on isolated guinea pig atria. J Cardiovasc Pharmacol 1985, 92: 307-15.
10. Chi JF, hu SH. Effects of 8-oxoberberine on sodium current in rat ventricular and human atrial myocytes. Can J Cardiol 1997,13: 1103-10.
11. Ying H, Siu-Chun H, Tak-Yuen C. Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats. Am J Chin Med 2002, 30 (4): 589-99.
12. Zeng XH, Zeng XJ, Li YY. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2003, 92(2): 173-6.
13. Liu JC, chan PO. The antihypertensive effect of the berberine derivative: 6-protoberberine in spontaneously hypertensive rats. Pharmacology 1999, 59 (6): 283-9.
14. Fatehi-Hassanabad Z, Jafarzadeh M, Tarhini A, Fatehi M. The antihypertensive and vasodilator effects of aqueous extract from Berberis vulgaris fruit on hypertensive rats. Phytother Res. 2005 19 (3): 222-225.
15. Fatehi M, Saleh TM, Fatehi-Hassanabad Z, Farrokhfal K, Jafarzadeh M, Davodi S. A pharmacological study on Berberis vulgaris fruit extract. J Ethnopharmacol 2005 102(1): 46-52.
16. Marin N JA. Cardiovascular effects of berberine in patients with sever congestive heart failure. Clin Cardiol 1988, 11(4): 253-60.
17. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004, 10: 1344-51.
18. Doggrell SA. Berberine - a novel approach to cholesterol lowering. Expert Opin Investig Drugs. 2005, 14: 683-5.
19. Chlopicki S, Kozlovski VI, Gryglewski RJ. No-dependent vasodilation induced by nebivolol in coronary circulation is not mediated by beta-adrenoceptors or by 5-HT1A-receptors. J Physiol Pharmacol 2002, 53 : 615-9.
20. 2 adrenoceptors. J Physiol Pharmacol 2003, 54: 511-515.
21. Sys SU, Boels PJ, Brutsaert DL. Positive inotropic and vasodilating effects of amrinone and milrinone in isolated canine heart. J Cardiovasc Pharmacol 1987, 10: 445-449.
22. England PJ, Shahid M. Effects of forskolin on contractile response and protein phosphorylation in the isolated perfused rat heart. Biochem J 1987, 246: 687-695.
23. 2+ sensitisation in idiopathic dilated human myocardium. Arzneim Forsch Drug Res 1996, 46: 586-593.
24. Herold P Herzig JW, Wenk, Leutert T, Zbinden P, Fuhrer W, Stutz S, Schenker, Meier M, Rihs G. 5-Methyl-6-phenyl 1, 3, 5, 6-tetrahydro-3, 6-methano-1, 5-benzodiazocine-2, 4-dione (BA 41899): representative of a novel class of purely calcium-Sensitizing agents. J Med Chem. 1995, 38: 2946-2954.
25. Kass D.A, Solaro R.J. Mechanisms and use of calcium-sensitizing agents in the failing heart. Circulation 2006, 113(2): 305-315.
26. Lang RM, Fellner SK, Neumann A, Bushinsky DA, Borow KM . Left Ventricular contractility varies directly with blood-ionized calcium. Ann Intern Med 1988, 108: 524-529.
27. Francis GS, Cohn J. Heart failure: mechanisms of cardiac and vascular dysfunction and the rationale for pharmacologic intervention. FASEB J 1990, 4: 3068-3075.